Report of Foreign Issuer (6-k)
31 August 2018 - 6:17AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
Form 6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER
THE
SECURITIES EXCHANGE ACT OF 1934
For
the month of August 2018
Commission
File Number 001-37846
CELLECT
BIOTECHNOLOGY LTD.
(Translation
of registrant’s name into English)
23
Hata’as Street
Kfar
Saba, Israel 44425
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7): ☐
On
August 30, 2018, Cellect Biotechnology Ltd. (the “Company”) convened an Extraordinary Meeting of Shareholders, however,
the meeting was adjourned for one week to the same day, time and place due to lack of quorum. Accordingly, the Company’s
Extraordinary Meeting of Shareholders will be reconvened on Thursday, September 6, 2018 at 11.00 a.m. (Israel time) at the offices
of the Company’s legal counsel – Doron, Tikotzky, Kantor, Gutman & Amit Gross, at B.S.R 4 Tower, 33rd Floor, 7
Metsada Street, Bnei Brak.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
Cellect Biotechnology Ltd.
|
|
|
|
|
By:
|
/s/
Eyal Leibovitz
|
|
|
Name: Eyal Leibovitz
|
Date: August 30, 2018
|
|
Title: Chief Financial Officer
|
Cellect Biotechnology (NASDAQ:APOP)
Historical Stock Chart
From Apr 2024 to May 2024
Cellect Biotechnology (NASDAQ:APOP)
Historical Stock Chart
From May 2023 to May 2024